Company Filing History:
Years Active: 2004-2007
Title: The Innovative Contributions of Elke Reissmueller
Introduction
Elke Reissmueller is a prominent inventor based in Bielefeld, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as NMDA-antagonists. With a total of 2 patents to her name, her work is recognized for its potential impact on pain treatment.
Latest Patents
Reissmueller's latest patents include the development of substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds. These compounds are designed as NMDA-antagonists and are aimed at providing new treatment methods for pain management. Additionally, she has patented substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, which further expand the possibilities for pharmaceutical applications.
Career Highlights
Reissmueller is currently associated with Gruenenthal GmbH, a company known for its focus on innovative pain management solutions. Her work at Gruenenthal has positioned her as a key player in the pharmaceutical industry, contributing to advancements that could improve patient care.
Collaborations
Throughout her career, Elke has collaborated with notable colleagues such as Matthias Gerlach and Michael Przewosny. These partnerships have fostered an environment of innovation and have led to the successful development of her patented compounds.
Conclusion
Elke Reissmueller's contributions to the field of pharmaceuticals highlight her role as an influential inventor. Her work on NMDA-antagonists and other compounds demonstrates her commitment to advancing pain treatment methodologies.